Bayer halts sales of anti-bleeding drug after Canadian trial identifies risks

TORONTO - Pharmaceutical giant Bayer AG suspended global sales of its anti-bleeding drug Trasylol on Monday after a clinical trial led by Ottawa researchers found the drug was linked to a higher risk of death than alternative medications. The action followed requests from the U....More